STOPPFall:高跌倒风险老年人处方筛查工具——EuGMS 跌倒风险增加药物工作组德尔菲研究
专家就纳入 STOPPFall 的 14 个药物类别达成一致,指出同一药理类别内不同亚类之间存在 18 项跌倒风险差异,并配套制定了实用减处方工具。
要点
- STOPPFall 纳入 14 个药物类别,多为精神活性药物,供高跌倒风险老年人处方筛查使用。
- 专家组就同一药理类别内亚类之间的 18 项跌倒风险差异达成共识。
- 工具配套实用减处方指导,其预防跌倒的效果尚待干预研究验证。
核心结论
- STOPPFall 经专家德尔菲共识制定,并结合旨在优化药物审查的实用减处方工具。
- 该工具预防跌倒的实际效果仍需进一步通过干预研究评估。
研究设计与样本
- STOPPFall 由两名促进者基于近期荟萃分析与欧洲各国跌倒预防指南的证据构建。
- 共识阈值预先设定为 70%。
- 另设问卷询问专家在哪些情况下应考虑对 FRIDs 减处方以及如何实施。
- 研究类型为德尔菲共识研究,来源期刊为 Age Ageing。
主要发现
- 专家组成员就纳入 STOPPFall 的 14 个药物类别达成一致,其中大多为精神活性药物。
- 专家组成员指出同一药理类别内不同亚类在跌倒风险增加特性上存在 18 项差异。
- 针对 STOPPFall 所列药物类别制定了实用减处方指导。
关键数值与推荐
- 纳入 STOPPFall 的药物类别共 14 个。
- 同一药理类别内亚类之间的跌倒风险差异共 18 项。
- 德尔菲共识阈值预先设定为 70%。
临床怎么用
- 对高跌倒风险老年人进行处方审查时可使用 STOPPFall 筛查 FRIDs,并结合配套减处方工具开展减处方。
- 因证据仍待干预研究验证,使用时应结合个体情况判断,不宜将其效果视为已确证。
局限性
- 摘要未报告专家组成员的地域构成、各条目具体同意比例及共识轮次间变化。
- 摘要未报告 STOPPFall 与减处方工具在临床结局上的验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Healthcare professionals are often reluctant to deprescribe fall-risk-increasing drugs (FRIDs). Lack of knowledge and skills form a significant barrier and furthermore, there is no consensus on which medications are considered as FRIDs despite several systematic reviews. To support clinicians in the management of FRIDs and to facilitate the deprescribing process, STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk) and a deprescribing tool were developed by a European expert group. METHODS: STOPPFall was created by two facilitators based on evidence from recent meta-analyses and national fall prevention guidelines in Europe. Twenty-four panellists chose their level of agreement on a Likert scale with the items in the STOPPFall in three Delphi panel rounds. A threshold of 70% was selected for consensus a priori. The panellists were asked whether some agents are more fall-risk-increasing than others within the same pharmacological class. In an additional questionnaire, panellists were asked in which cases deprescribing of FRIDs should be considered and how it should be performed. RESULTS: The panellists agreed on 14 medication classes to be included in the STOPPFall. They were mostly psychotropic medications. The panellists indicated 18 differences between pharmacological subclasses with regard to fall-risk-increasing properties. Practical deprescribing guidance was developed for STOPPFall medication classes. CONCLUSION: STOPPFall was created using an expert Delphi consensus process and combined with a practical deprescribing tool designed to optimise medication review. The effectiveness of these tools in falls prevention should be further evaluated in intervention studies.
引用
- Seppala LJ, Petrovic M, Ryg J, et al. STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Age Ageing. 2021. PMID: 33349863. doi:10.1093/ageing/afaa249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。